FreshLeaf Analytics

TGA Approves Record Breaking Number of Australian Medicinal Cannabis Patients

As a result, the overall number of approved applications for medicinal cannabis products has climbed to approximately 67,000.The Therapeutic Goods Administration (TGA) approved a r...

Australian Cannabis Companies Fail TGA Testing Requirements

The affected companies have pledged to resolve the inconsistencies, which were uncovered as part of routine surveillance conducted by the TGA.The Therapeutic Goods Administration (...

FreshLeaf Analytics Q3 Cannabis Report Reveals Biggest Price Drop Since 2016

Cannabis industry revenue is also expected to triple during 2020—growing to approximately $95 million—while active patient numbers are on schedule to reach 30,000 before the ye...

Australian Government Legalizes Over-The-Counter CBD

The rescheduling will be limited to oral, mucosal and sublingual CBD products, which means that vaping, topical creams and smokables will remain illegal.Earlier today the Australia...

TGA Announces Delay to Decision on Epidyolex Subsidies

However, the PBAC's decision was "a deferment, not a rejection", according to a statement from FreshLeaf Analytics. The Pharmaceutical Benefits Advisory Committee (PBAC) has offici...

FreshLeaf Analytics Strengthens Management Team with Innovation Specialist Cassandra Hunt

Cassandra will be joining the company as Managing Director, while also sitting on FreshLeaf Analytics' advisory board. There was big news from FreshLeaf Analytics—which operatesa...

Analyzing the Australian Cannabis Industry With Rhys Cohen

We sat down with FreshLeaf Analytics' Principal Consultant, Rhys Cohen, about his thoughts on Australia's cannabis industry and the future of cannabis. Australia's medical cannabis...

May Sees Record High SAS-B Approvals For Cannabis Medicines

Medicinal cannabis approvals in Australia via the Special Access Scheme Category B route saw 4,133 approvals for the month of May 2020. For the month of May, the number of Australi...

Australian Medical Marijuana Prescriptions Steady Amid COVID-19

Medicinal cannabis approvals in Australia via the Special Access Scheme Category B route saw 3,378 prescriptions for the month of April 2020. The COVID-19 crisis has brought the Au...

Australia's Most Comprehensive Medicinal Cannabis Report Published for Q1 2020

FreshLeaf Analytics has released an in-depth analysis of the patients, products and pricing of the Australian cannabis industry for Q1 2020.The Southern Cannabis Holding Company's ...